MedTrace Logo

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

NCT01654328 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2015-04-01

No results posted yet for this study

Summary

The purpose of this study is to investigate if home-hydration is a non inferior alternative for in-hospital hydration in the prevention of Contrast Induced Nephropathy in high risk patients.

Conditions

  • Radiographic Contrast Agent Nephropathy

Interventions

DRUG

Sodium chloride tablets

sodium chloride 1g/10kg of body weight /day per os on day -2 and -1 before contrast exposure. With a maximum dose of 10 gram sodium chloride a day.

DRUG

Isotonic saline intravenously

isotonic saline (Nacl 0.9%) total 1000ml in 4 hrs or (in case of heart failure or severe renal failure) 12 hrs before and in 4 or in 12 hrs after contrast administration.

Sponsors & Collaborators

  • Prof. Dr. J. Wetzels

    lead OTHER

Principal Investigators

  • Jack Wetzels, MD · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654328 on ClinicalTrials.gov